Additionally, TANs in NSCLC can produce high levels of interleukin-17 (IL-17), which can promote tumor growth and metastasis by inducing angiogenesis and suppressing the activity of T cells [70]. The gene discussed is IL17A; the disease is non-small cell lung carcinoma.